Test Price
1,800 AED✅ Home Collection Available
Insulin Free (Bioactive) Test in UAE | 1,800 AED | DHA Licensed Diagnostic Endocrinology
Executive Summary & Core Metrics
Executive Summary: High-precision quantification of bioactive free insulin for endocrine and metabolic assessment, processed under DHA-licensed protocols at DNA Labs UAE. This test delivers clinically actionable data for insulin resistance, hypoglycaemia evaluation, and pancreatic beta-cell function analysis.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation with a DHA-licensed General Practitioner.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The Insulin Free (Bioactive) Test precisely measures the biologically active fraction of insulin, excluding interference from proinsulin and antibody-bound insulin, using a specialised high-sensitivity immunoassay. This test is essential for accurate assessment of pancreatic beta-cell function, insulin resistance monitoring, and hypoglycaemia evaluation, with results reported within 2–3 weeks after sample collection. The assay employs epitope-specific detection that isolates only the unbound, physiologically active insulin molecules, providing a true functional readout of pancreatic secretory capacity.
| Parameter | Our Test (Bioactive Insulin Free) | Closest Alternative (Total Insulin Immunoassay) |
|---|---|---|
| Precision | 99.9% diagnostic sensitivity; specifically targets free, active insulin | Measures total immunoreactive insulin including proinsulin, reducing specificity |
| Methodology | Specialised high-sensitivity immunoassay (bioactive epitope detection) | Conventional immunoassay (total insulin, variable cross-reactivity) |
| Turnaround Time | 2–3 weeks (batch processing for precision) | 1–3 days (routine lab) |
| Clinical Utility | Differentiates true insulin activity from interference; ideal for insulinoma work-up and anti-aging protocols | General diabetes screening, less reliable in presence of insulin antibodies |
Physician Insight & Safety Protocols
“As a DHA-licensed General Practitioner, I emphasise that accurate insulin assessment requires correlation with glucose, C-peptide, and clinical presentation to avoid diagnostic pitfalls. The bioactive insulin free test provides targeted measurement of physiologically active insulin, essential for evaluating hypoglycaemia and insulin resistance. Always interpret laboratory results within the full clinical context.”
— Dr. Ajay Singh, General Practitioner, DHA License: 36234132
Medication Advisory
Do not discontinue or alter any prescribed medication without prior consultation with your treating physician. Abrupt changes to insulin or oral hypoglycaemic agents can lead to dangerous metabolic disturbances. Always discuss test results with your doctor before making therapeutic decisions.
Exclusion Criteria & Safety Red Flags
- Exclusion Criteria: Active infection, recent surgery, or high-dose biotin supplementation (may interfere with assay).
- Immediate Medical Attention: Severe hypoglycaemia (blood glucose < 50 mg/dL) with confusion, seizure, or loss of consciousness — proceed to ER regardless of test status.
- Paediatric & Maternal: For minors, written parental consent is mandatory, and an 8–12 hour overnight fast must be strictly observed. Federal Decree-Law No. 4 of 2016 on Medical Liability governs all clinical safety and patient consent protocols.
Patient FAQ & Clinical Guidance
1. What does the Insulin Free (Bioactive) Test measure?
This test specifically quantifies only the unbound, biologically active insulin molecules in serum, not total immunoreactive insulin. It uses an advanced immunoassay that recognises the bioactive epitope, avoiding interference from proinsulin and insulin-like growth factors, delivering a true picture of pancreatic output and tissue sensitivity.
2. Why is overnight fasting mandatory for this test?
Overnight fasting stabilises basal insulin secretion, eliminating postprandial spikes that can mask true fasting levels. Without an 8–12 hour fast, food intake artificially elevates insulin, compromising diagnostic accuracy for insulin resistance, insulinoma, or fasting hypoglycaemia assessment. Water is permitted during the fast.
3. How long does it take to get results and what do I do next?
Results are typically reported within 2–3 weeks, after which a teleconsultation with our DHA-licensed General Practitioner is arranged. The specialised processing requires batch shipment; once available, we proactively schedule a post-test clinical guidance call to review the findings with your referring physician.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE operates in full compliance with UAE federal data protection and healthcare technology regulations. All patient data is handled under the following legal frameworks:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) — governing the lawful collection, processing, and storage of personal health data with patient consent and data subject rights.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields — regulating health information systems, electronic medical records, and digital clinical data exchange.
- Federal Decree-Law No. 4 of 2016 on Medical Liability — ensuring patient safety protocols, informed consent standards, and clinical accountability.
All laboratory processes are ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139). For data subject rights requests, contact the Data Protection Officer at DNA Labs UAE.
Clinical & Logistical Metadata
| Test Name | Insulin Free (Bioactive) Test |
| Price (AED) | 1,800 |
| Turnaround Time | 2–3 Weeks |
| Sample Type / Matrix | Serum (Peripheral Whole Blood) |
| Methodology Used | High-Sensitivity Immunoassay (Bioactive Epitope Detection) |
| ICD-10-CM Code | E16.8, Z13.1 |
| LOINC Code | 20448-7 |
| DHA Facility License & Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians